INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845P908. A total of 6 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,038,240 | +479.5% | 56,000 | +245.7% | 0.00% | – |
| Q2 2023 | $179,172 | +303581.4% | 16,200 | +237.5% | 0.00% | – |
| Q4 2022 | $59 | -100.0% | 4,800 | -95.1% | 0.00% | – |
| Q3 2022 | $1,380,000 | +1990.9% | 98,900 | +1960.4% | 0.00% | – |
| Q2 2022 | $66,000 | -73.5% | 4,800 | -68.6% | 0.00% | – |
| Q4 2021 | $249,000 | +173.6% | 15,300 | +150.8% | 0.00% | – |
| Q3 2021 | $91,000 | -88.5% | 6,100 | -14.1% | 0.00% | – |
| Q1 2019 | $794,000 | -68.5% | 7,100 | -76.3% | 0.00% | -100.0% |
| Q2 2018 | $2,517,000 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 47,800 | $32,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 292,600 | $4,041,000 | 0.01% |
| JANE STREET GROUP, LLC | 164,200 | $2,268,000 | 0.00% |
| SIMPLEX TRADING, LLC | 70,400 | $972,000 | 0.00% |
| JPMORGAN CHASE & CO | 4,800 | $66,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |